首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production.
【2h】

Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production.

机译:博莱霉素诱导的仓鼠肺纤维化。肺泡巨噬细胞产品可增加成纤维细胞前列腺素E2和环状单磷酸腺苷并抑制成纤维细胞增殖和胶原蛋白的产生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bleomycin-induced pulmonary fibrosis in hamsters is associated with collagen accumulation that results from increased lung collagen synthesis rates. However, 1-2 wk after intratracheal instillation of bleomycin, lung collagen synthesis rates decline toward control values. To evaluate the potential role of the bronchoalveolar macrophage in regulating lung collagen production, we studied the effects of macrophages from normal and bleomycin-treated hamsters upon fibroblasts in vitro. We observed: (a) Medium from macrophage cultures decreased fibroblast [3H]thymidine incorporation and nondialyzable [3H]hydroxyproline production in a dose-dependent manner. Fibroblast cell counts were decreased in exposed cultures, and fibroblast viability was unchanged. Procollagen prolyl hydroxylation and prolyl-transfer RNA-specific activity were not altered by macrophage medium; this indicates that [3H]hydroxyproline reflects collagen production rate under the experimental conditions. (b) The suppressive effect of macrophage medium was selective for collagen since collagen production decreased more than noncollagen protein production. (c) Medium from bleomycin-treated hamster macrophages suppressed fibroblast proliferation and collagen production to a greater degree than medium from normal hamster macrophages. (d) Fibroblast suppression by macrophage medium was associated with increased fibroblast endogenous prostaglandin E2 production and intracellular cyclic AMP (cAMP). (e) Incubation of fibroblasts with indomethacin before exposure completely inhibited prostaglandin E2 production and increases in cAMP, and eliminated suppression of fibroblast proliferation and collagen production. The macrophage-derived suppressive factor has an apparent molecular weight of 20,000-30,000 and is heat stable. It does not appear to be species restricted since both hamster and human lung fibroblasts are similarly suppressed. It is at least in part preformed in macrophages obtained by lavage, but its production can also be stimulated in vitro. We concluded that alveolar macrophages release a product that stimulates endogenous fibroblast prostaglandin E2 production and cAMP formation with resultant suppression of fibroblast proliferation and collagen production. Enhanced release of suppressive factor by macrophages during a time when lung collagen production is declining in bleomycin-induced pulmonary fibrosis suggests that macrophages may limit collagen accumulation in pulmonary fibrosis.
机译:博莱霉素诱导的仓鼠肺纤维化与胶原蛋白积聚有关,而胶原蛋白积聚是由于肺胶原蛋白合成速率增加所致。然而,气管内滴注博来霉素后1-2周,肺胶原合成速率朝着对照值下降。为了评估支气管肺泡巨噬细胞在调节肺胶原产生中的潜在作用,我们研究了正常和博来霉素处理仓鼠的巨噬细胞对成纤维细胞的影响。我们观察到:(a)来自巨噬细胞培养的培养基以剂量依赖的方式减少了成纤维细胞[3H]胸苷的掺入和不可透析的[3H]羟基脯氨酸的产生。在暴露的培养物中成纤维细胞计数减少,成纤维细胞活力不变。巨噬细胞培养基不会改变原胶原的脯氨酰羟化和脯氨酰转移RNA的特异性活性。这表明[3H]羟基脯氨酸反映了实验条件下的胶原蛋白产生速率。 (b)巨噬细胞培养基对胶原的抑制作用是选择性的,因为胶原的产生比非胶原蛋白的产生减少更多。 (c)博来霉素处理过的仓鼠巨噬细胞的培养基比正常仓鼠巨噬细胞的培养基更能抑制成纤维细胞的增殖和胶原蛋白的产生。 (d)巨噬细胞培养基对成纤维细胞的抑制作用与成纤维细胞内源性前列腺素E2的产生和细胞内环状AMP(cAMP)的增加有关。 (e)在接触前将成纤维细胞与吲哚美辛一起孵育会完全抑制前列腺素E2的产生并增加cAMP的含量,并消除对成纤维细胞增殖和胶原蛋白产生的抑制作用。巨噬细胞来源的抑制因子的表观分子量为20,000-30,000,并且是热稳定的。它似乎不受物种限制,因为仓鼠和人肺成纤维细胞均受到类似的抑制。它至少部分在通过灌洗获得的巨噬细胞中预先形成,但是其产生也可以在体外被刺激。我们得出的结论是,肺泡巨噬细胞释放出一种刺激内源性成纤维细胞前列腺素E2产生和cAMP形成的产物,从而抑制了成纤维细胞增殖和胶原蛋白的产生。在博来霉素诱导的肺纤维化中,肺胶原蛋白的含量下降时,巨噬细胞抑制因子的释放增强,这表明巨噬细胞可能会限制胶原蛋白在肺纤维化中的积累。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号